Phenotypic data of the 10 patients with von Willebrand disease
Patient . | Sex . | Age, y . | BT, min . | vWF:Ag, U/dL . | RCoF, U/dL . | RCoF/ vWF:Ag . | vWF:CBA, U/dL . | VIII:c, U/dL . | RIPA, 1.3 mg/mL . | RIPA, 0.5 mg/mL . | Platelet count, 109cells per L . |
---|---|---|---|---|---|---|---|---|---|---|---|
A1 propositus | M | 44 | >20 | 17 | 6 | 0.35 | 8 | 25 | — | — | 412 |
A2 sister | F | 41 | — | 18 | 9 | 0.50 | 12 | 29 | nil* | nil | 294 |
A3 son | M | 12 | 17 | 20 | 6 | 0.30 | 7.5 | 38 | — | — | 445 |
A4 nephew | M | 10 | >20 | 21 | 8 | 0.38 | 14 | 42 | nil | nil | 296 |
B1 propositus | F | 31 | >20 | 19 | 5 | 0.26 | — | 24 | decreased | nil | 221 |
B2 uncle | M | 47 | >20 | 25 | 12 | 0.48 | — | 57 | nil | nil | 218 |
C1 propositus | F | 44 | 15.5 | 18 | 5 | 0.28 | — | 48 | nil | nil | 284 |
D1 propositus | F | 33 | 20 | 20 | 4 | 0.20 | — | 27 | nil | nil | 227 |
E1 propositus | F | 26 | >20 | 30 | 18 | 0.60 | — | 58 | decreased | nil | 307 |
F1 propositus | M | 54 | >20 | 18 | 8 | 0.44 | 9 | 50 | decreased | nil | 254 |
normal range | 4-8 | 50-150 | 50-150 | ≥0.7 | 50-150 | 50-150 | 150-400 |
Patient . | Sex . | Age, y . | BT, min . | vWF:Ag, U/dL . | RCoF, U/dL . | RCoF/ vWF:Ag . | vWF:CBA, U/dL . | VIII:c, U/dL . | RIPA, 1.3 mg/mL . | RIPA, 0.5 mg/mL . | Platelet count, 109cells per L . |
---|---|---|---|---|---|---|---|---|---|---|---|
A1 propositus | M | 44 | >20 | 17 | 6 | 0.35 | 8 | 25 | — | — | 412 |
A2 sister | F | 41 | — | 18 | 9 | 0.50 | 12 | 29 | nil* | nil | 294 |
A3 son | M | 12 | 17 | 20 | 6 | 0.30 | 7.5 | 38 | — | — | 445 |
A4 nephew | M | 10 | >20 | 21 | 8 | 0.38 | 14 | 42 | nil | nil | 296 |
B1 propositus | F | 31 | >20 | 19 | 5 | 0.26 | — | 24 | decreased | nil | 221 |
B2 uncle | M | 47 | >20 | 25 | 12 | 0.48 | — | 57 | nil | nil | 218 |
C1 propositus | F | 44 | 15.5 | 18 | 5 | 0.28 | — | 48 | nil | nil | 284 |
D1 propositus | F | 33 | 20 | 20 | 4 | 0.20 | — | 27 | nil | nil | 227 |
E1 propositus | F | 26 | >20 | 30 | 18 | 0.60 | — | 58 | decreased | nil | 307 |
F1 propositus | M | 54 | >20 | 18 | 8 | 0.44 | 9 | 50 | decreased | nil | 254 |
normal range | 4-8 | 50-150 | 50-150 | ≥0.7 | 50-150 | 50-150 | 150-400 |
BT indicates bleeding time; vWF, von Willebrand factor; Ag, antigen; RCoF, ristocetin cofactor activity; CBA, collagen binding activity; VIII:c, factor VIII coagulant activity; RIPA, ristocetin-induced platelet agglutination.
Undetectable RIPA at the ristocetin concentration tested.